Active ETFs: the story two-thirds of the way through 2026

In this week’s ETF show, we drill into the year’s winners and laggards—and what is driving the differences. ARK’s genomics ETF has jumped 27% in a month, taking its annual gain towards 100%, while emerging-market ETFs from JPMorgan, Fidelity and Avantis have outpaced their global counterparts. But the headline returns conceal sharply divergent fortunes. We explore the semiconductor boom powering Korea and Taiwan, the reversal in provider rankings between emerging and global markets, and the 14-percentage-point gap between JPMorgan’s US value and growth ETFs. Has August’s rebound changed the picture, or simply repaired some of the earlier damage? This information is only suitable for persons in the UK or EU. QuotedData is a trading name of Marten & Co which is authorised and regulated by the Financial Conduct Authority. QuotedData publishes free, reliable educational resources, research and news on carefully selected sectors and companies, some of which is sponsored. UK investment companies and REITs form the core of our coverage, offering investors a professional investor quality service. In addition, we provide data, including performance charts and statistics, across the full spectrum of pan-European equities. Our team of expert analysts writes with a balanced view and our goal is to provide you with the information you need to make your own investment decisions, or to understand in more detail what your adviser is recommending to you. #quoteddata #etf #investing #strategies #europe #stocks #equity #trading